SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036769
Filing Date
2020-08-05
Accepted
2020-08-05 16:00:39
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-10q_20200630.htm 10-Q 2201690
2 EX-31.1 alrn-ex311_8.htm EX-31.1 16317
3 EX-31.2 alrn-ex312_6.htm EX-31.2 16193
4 EX-32.1 alrn-ex321_7.htm EX-32.1 7916
5 EX-32.2 alrn-ex322_9.htm EX-32.2 7029
  Complete submission text file 0001564590-20-036769.txt   6800593

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrn-20200630.xml EX-101.INS 1319337
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20200630.xsd EX-101.SCH 44022
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20200630_cal.xml EX-101.CAL 39313
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20200630_def.xml EX-101.DEF 155110
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20200630_lab.xml EX-101.LAB 380535
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20200630_pre.xml EX-101.PRE 299017
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 201077120
SIC: 2834 Pharmaceutical Preparations